x

Coronavirus

BioNTech to Starting Manufacturing Its COVID-19 Vaccine in Germany

February 10, 2021

BERLIN — BioNTech says it has starting manufacturing its COVID-19 vaccine at a new site in Germany, an important step toward increasing global supplies of one of the main vaccines against the coronavirus.

BioNTech, a German company that partnered with Pfizer to produce the first vaccine approved for use in Europe and the U.S., said Wednesday that it has started the manufacturing process at Marburg in central Germany by producing mRNA, the active pharmaceutical ingredient of the product.

The company said that quality tests will be performed internally and externally before the vaccine is released, and the new facility’s production processes will need approval from the European Medicines Agency so that the vaccine can be shipped. The first vaccines manufactured in Marburg are scheduled for distribution in early April.

The site, which BioNTech purchased from Switzerland’s Novartis, will be able to produce up to 750 million doses of the COVID-19 vaccine per year once fully operational.

An initial shortage of production capacity has been a key bottleneck in the rollout of vaccines, particularly in the European Union.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.